About Diagnox
DiagnOx was established to help improve the commercialisation of the UK's world-class diagnostics research through the development of a programme of services tailored to meet the needs of the sector.
DiagnOx was initially awarded funding through the DTI's Biotechnology Exploitation Platform (BEP) Challenge. Government has long recognised the strength of the UK in producing world-class medical research but subsequent commercial exploitation has been an area of persistent weakness. The BEP Challenge initiative was introduced to try and rectify this position.
The design of the DiagnOx services has been guided by a Steering Committee with representation from across the sector including; British In Vitro Diagnostics Association (BIVDA); The Diagnostics Club; Universities and NHS Trusts (IP generators); plus major international diagnostic companies and smaller companies.
DiagnOx membership has grown rapidly and now includes researchers, new businesses, established businesses, organisations and professionals with an interest in the UK diagnostics sector. To join the DiagnOx network click here
|
